Current Endocrine Disruptors News and Events

Current Endocrine Disruptors News and Events, Endocrine Disruptors News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Study shows new treatment pathway to prevent and treat endometrial cancer recurrence
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer. (2021-02-23)

Study finds risk factor for blood clots occurs in more than 10 percent of transgender men using testosterone
A potentially dangerous side effect of testosterone therapy for transgender men is an increase in red blood cells that can raise the risk of blood clots, heart attack or stroke, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2021-02-18)

Molecular imaging determines effectiveness of novel metastatic breast cancer treatment
Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy. (2021-02-16)

Chinese people may be more susceptible to obesity-related health risks than other racial, ethnic groups
Chinese people are more likely to face high blood pressure and other health risks as a result of higher body mass index (BMI) and waist circumference than people from other racial and ethnic groups, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2021-02-11)

Sleep keeps teens on track for good mental health
As families settle back into a new school year, sleep experts at the University of South Australia are reminding parents about the importance of teenagers getting enough sleep, cautioning them that insufficient sleep can negatively affect their mental health. (2021-02-10)

Effectiveness of endocrine therapy for breast cancer in men
This randomized clinical trial looked at changes in levels of the hormone estradiol in men with hormone receptor-positive breast cancer after three months of treatment with endocrine therapies. (2021-02-04)

Researchers assess cognitive impairment in patients with breast cancer
A recent analysis of published studies in Psycho-Oncology estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. (2021-02-03)

'Zoombombing' research shows legitimate meeting attendees cause most attacks
Most zoombombing incidents are ''inside jobs'' according to a new study featuring researchers at Binghamton University, State University of New York. (2021-02-03)

Addressing health disparities in diabetes requires a broader look at systemic racism
Poor social conditions caused by systemic racism contribute to health disparities in people with diabetes, according to a paper published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2021-01-26)

New discovery in breast cancer treatment
Researchers at the University of Adelaide have found new evidence about the positive role of androgens in breast cancer treatment with immediate implications for women with estrogen receptor-driven metastatic disease. (2021-01-18)

Endocrine Society recommends government negotiation and other policies to lower out-of-pocket costs
The Endocrine Society is calling on policymakers to include government negotiation as part of an overall strategy to reduce insulin prices in its updated position statement published today in The Journal of Clinical Endocrinology & Metabolism. (2021-01-12)

Black people with type 1 diabetes, COVID-19 are four times more likely to be hospitalized for diabetic ketoacidosis
Black and Hispanic people with COVID-19 and diabetes are more likely than Caucasians to die or have serious complications, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2021-01-07)

Artificial intelligence predicts gestational diabetes in Chinese women
Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-12-22)

Exposure to metals can impact pregnancy
Exposure to metals such as nickel, arsenic, cobalt and lead may disrupt a woman's hormones during pregnancy, according to a Rutgers study. (2020-12-21)

Hormone metabolites found in poop give researchers new insight into whale stress
Poop samples are an effective, non-invasive tool for monitoring gray whale reproduction, stress and other physiological responses. (2020-12-21)

Discriminatory policies threaten care for transgender, gender diverse individuals
The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism. (2020-12-16)

Plastics pose threat to human health
Plastics contain and leach hazardous chemicals, including endocrine-disrupting chemicals (EDCs) that threaten human health. An authoritative new report, Plastics, EDCs, & Health, from the Endocrine Society and the IPEN (International Pollutants Elimination Network), presents a summary of international research on the health impacts of EDCs and describes the alarming health effects of widespread contamination from EDCs in plastics. (2020-12-15)

Screening for endocrine disruption in artificial zebrafish for long-term risk assessment
the Korea Institute of Science and Technology (KIST) announced that the collaborative research team led by Dr. Young Jun Kim, leader of environmental safety at KIST Europe, and Professor Hyunjoon Kong from the University of Illinois at Urbana-Champaign tried to develop the long-term toxicity and risks by cultivating organoids that mimic the liver of zebrafish. (2020-12-11)

Different forms of sugar impact hunger-suppressing hormones in young adults
Drinks with sucrose compared to glucose may cause young adults to produce lower levels of appetite-regulating hormones, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-12-10)

High-risk, HR+, HER2-, early-stage BC patients continue to benefit from abemaciclib
Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium. (2020-12-09)

Postmenopausal women with early-stage BC/low recurrence score could skip adjuvant chemo
After a median follow-up of 5.1 years, among women with lymph node-positive early-stage breast cancer and a recurrence score of 25 or lower who received adjuvant endocrine therapy with or without chemotherapy, postmenopausal patients had no added benefit from chemotherapy, while premenopausal patients who received chemotherapy had improved invasive disease-free survival (IDFS) and an early indication of improved overall survival (OS), according to data from the SWOG S1007 RxPONDER clinical trial. (2020-12-09)

Gastric bypass surgery leads to long-term diabetes remission
More than half of adults with obesity had long-term diabetes remission following gastric bypass surgery, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-12-03)

SWOG Cancer Research Network hits SABCS with high impact research
SWOG Cancer Research Network members will share results of five network-led studies at the San Antonio Breast Cancer Symposium, or SABCS, an international gathering of breast cancer physicians and researchers expected to draw 8,000 virtual attendees from more than 80 countries that runs Dec. 8-11. (2020-12-02)

Lovestruck by oxytocin! Novel roles of the hormone in controlling male sexual function
Hormones are the master regulators of sexual functions in mammals. The hormone oxytocin has a well-established role in social bonding, sexual function, maternal instinct, nursing, and lactation. Researchers from Okayama University have now explored the roles of oxytocin in male sexual function for the first time. Findings from the study suggest that oxytocin-mediated control of male sexual function via the spinal cord may in fact be instrumental in treating erectile dysfunction. (2020-11-18)

New research supports clinical utility of CTC count for metastatic breast cancer
Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study providing support for the reliability of using circulating tumor cell (CTC) count to guide frontline therapy choice for patients with estrogen receptor-positive (ER+), HER2-negative (HER2) metastatic breast cancer. Published in the November issue of JAMA Oncology, this is the first study to support clinical utility of CTC count in a randomized clinical trial. (2020-11-09)

Young survivors of acute myeloid leukemia have long-term complications from treatment
Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications after treatment, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications were cardiovascular, endocrine and respiratory diseases. The complications - known as late effects - were more present among non-white AYA patients and those living in more deprived neighborhoods. (2020-11-09)

Copolymer helps remove pervasive PFAS toxins from environment
Researchers have demonstrated that they can attract, capture and destroy PFAS - a group of federally regulated substances found in everything from nonstick coatings to shampoo and nicknamed ''the forever chemicals'' due to their persistence in the natural environment. (2020-10-29)

Adults with endocrine disorders have an increased risk of heart disease
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society. (2020-10-28)

Study finds over 80 percent of COVID-19 patients have vitamin D deficiency
Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-10-27)

COVID-19 patients with spinal fractures are twice as likely to die
Patients with COVID-19 and vertebral fractures are twice as likely to die from the disease, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-10-21)

Legacy pollutants found in migratory terns in Great Lakes region
Chemicals that haven't been manufactured in the U.S. for years or even decades are still turning up in the bodies of migratory terns in the Great Lakes region, a new study finds. The research focused on three types of compounds: PBDEs, PCBs, and the breakdown products, called metabolites, of DDT. (2020-10-21)

COVID-19 pandemic drives innovation in diabetes care
The COVID-19 pandemic has jumpstarted innovation in health care delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-10-20)

A CNIO team describes how a virus can cause diabetes
* CNIO researchers have discovered the molecular mechanism by which coxsackievirus type B4 affects the functions and identity of beta cells that generate insulin, therefore promoting diabetes * They suggest to explore whether the potential of some drugs tested for cancer treatment in combination with antiviral therapies could be effective as a prevention and therapeutic strategy * The finding could be relevant to face the COVID-19 pandemic, since recent clinical information indicates that the SARS-CoV-2 virus might also promote diabetes in some patients (2020-10-20)

Consumers who avoid products with harmful chemicals on the label have lower body burden
New research shows that paying close attention to what's in the products you buy can pay off. In a study led by Silent Spring Institute, researchers found that consumers who avoided products containing specific endocrine disruptors had significantly lower levels of the chemicals in their bodies. (2020-09-30)

COVID-19 and type 2 diabetes: do shared pathways have therapeutic implications?
During a special COVID-19 session at this year's online Annual Meeting of the European Association for the Study of Diabetes (EASD), Prof. Daniel J. Drucker (Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Canada) will present a new review of the latest clinical findings linking diabetes to risk of infection and differential outcomes in people with COVID-19 infection. (2020-09-22)

Detection of PCBs and their metabolites (OH-PCBs) in the fetal brain of a Japanese macaque
This study selected the Japanese macaque (Macaca fuscata) as a model animal for the fetal transfer of OH-PCBs in humans, and revealed OH-PCB concentrations and their relationships in the maternal and fetal brains. The key finding from this study is that OH-PCBs can reach the developing brain of the fetus as early as the first trimester of pregnancy. These OH-PCBs may exceed the levels that induce adverse effects on neurodevelopment. (2020-09-14)

Studies show strong links between the endocrine system and COVID-19 incidence and mortality
COVID-19 and interlinkages to endocrine and metabolic diseases was an important programme topic at the 2020 European Congress of Endocrinology. With 4675 attendees from 112 countries this is the premier European endocrine meeting. Over 5 days, panel sessions covered the science behind COVID-19 and endocrine and metabolic disorders, as well as e-consulting and e-support to endocrine patients in times of COVID-19. (2020-09-14)

More chemicals can be assessed for endocrine disrupting effects
A European guidance document aimed at identifying endocrine disrupting pesticides can--with some modifications--be used to assess other chemicals' endocrine disrupting effects. This is the finding of a new study conducted by the National Food Institute, Technical University of Denmark, and Copenhagen University Hospital. (2020-09-09)

Thyroid inflammation linked to anxiety disorders
Patients with autoimmune inflammation of their thyroid may be at greater risk of developing anxiety, according to a study being presented at e-ECE 2020. The study found that people with anxiety may also have inflammation in their thyroid gland that can be reduced by taking the non-steroidal anti-inflammatory, ibuprofen. These findings suggest that thyroid function may play an important role in the development of anxiety disorders. (2020-09-06)

Obesity may alter immune system response to COVID-19
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology. (2020-09-03)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.